Request Demo
Last update 23 Jan 2025
HH-30134
Last update 23 Jan 2025
Overview
Basic Info
Drug Type Small molecule drug |
Synonyms + [1] |
Target |
Mechanism AXL inhibitors(AXL receptor tyrosine kinase inhibitors), FLT3 inhibitors(Tyrosine-protein kinase receptor FLT3 inhibitors), NTRK inhibitors(Neurotrophic tyrosine kinase receptor inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization- |
Active Organization |
Inactive Organization |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with HH-30134CTR20210900
一项评估HH30134在晚期实体瘤患者中的安全性、耐受性和药代动力学的I期、多中心、开放的首次人体试验
[Translation] A Phase I, multicenter, open-label, first-in-human trial evaluating the safety, tolerability, and pharmacokinetics of HH30134 in patients with advanced solid tumors
NCT04746612
A Phase I, Multi-centre, Open-Label, First in Human Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of HH30134 in Patients With Advanced Solid Tumours
100 Clinical Results associated with HH-30134
Login to view more data
100 Translational Medicine associated with HH-30134
Login to view more data
100 Patents (Medical) associated with HH-30134
Login to view more data
100 Deals associated with HH-30134
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 2 | CN | 08 Apr 2021 | |
| Advanced Malignant Solid Neoplasm | Phase 2 | AU | 08 Apr 2021 | |
| Neoplasms | Preclinical | - | - |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free